Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Catherine Bollard

Catherine Bollard

individual
Capital ownerEcosystem influencer

About

Catherine Bollard, MD, MBChB, is a pediatric hematologist-immunologist and cell therapy researcher who serves as Senior Vice President and Chief Research Officer at Children's National Hospital and as a professor at George Washington University. She is a board member of Cabaletta Bio and the Alliance for Regenerative Medicine, and she has held prominent scientific leadership roles including president of FACT. Bollard has also helped found cell-therapy companies including MANA Therapeutics and Catamaran Bio, reflecting a translational bridge between academic research and biotech commercialization.

Areas of interest

biotechcell therapyimmunotherapygene therapypediatric oncologycancer researchhematologyimmunologyviral immunologytranslational medicine